Evolutionary therapy (ET) needs accurate tumour burden tracking.
"RECIST misses disease progression by months and ET must be guided by 3D measurements"

@katstankova.bsky.social @tpmtudelft.bsky.social @erasmusmc.bsky.social #erasmus #cancerevolution

doi.org/10.1093/jeb/...